Hepatitis C Stocks

Description:

This portfolio consists of public companies that are researching a cure for Hepatitis C which affects 170 million people worldwide

"The hottest area in drug development right now and for the next couple of years is hepatitis C," said Kris Jenner, whow runs the $1.7 billion T. Rowe Price Health Sciences Fund.

Most Viewed Portfolios

View All

Articles

4 Huge Stocks on Traders' Radars

10.20.14 | 01:45 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

5 Hated Earnings Stocks You Should Love

10.20.14 | 01:15 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a t...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter